August 16, 2021
The Washington Department of Health (DOH) released a statement on Saturday, August 14 providing guidance to health care providers regarding administration of third doses of Pfizer-BioNTech and Moderna COVID-19 vaccines to certain immunocompromised individuals. This statement follows recommendations made by the U.S. Food and Drug Administration (FDA), Advisory Committee on Immunizations Practices (ACIP), and Western States Scientific Safety Review Workgroup.
While authorized vaccines have proven to be more than 90% effective in protecting against most variants, emerging data suggest people with moderately to severely compromised immune systems do not always build the same level of immunity compared to people who are not immunocompromised. The third dose is not considered a booster, rather an additional dose for individuals who did not adequately develop immunities with the initial two-dose series.
People are asked to speak with their healthcare provider about their medical condition, and whether getting an additional dose is appropriate for them. CDC does not recommend additional doses or booster shots for any other population at this time.
Currently, CDC is recommending that moderately to severely immunocompromised people receive an additional dose. This includes people who have:
- Been receiving active cancer treatment for tumors or cancers of the blood
- Received an organ transplant and are taking medicine to suppress the immune system
- Received a stem cell transplant within the last 2 years or are taking medicine to suppress the immune system
- Moderate or severe primary immunodeficiency (such as DiGeorge syndrome, Wiskott-Aldrich syndrome)
- Advanced or untreated HIV infection
- Active treatment with high-dose corticosteroids or other drugs that may suppress your immune response
A full list of conditions is available on the CDC’s website.
A person receiving a third dose should get it at least 28 days after their second dose. When possible, the individual should receive the same vaccine as the first two doses but may receive the other mRNA vaccine brand if the other vaccine is not available.
There is not enough data at this time to determine whether immunocompromised people who received the Johnson & Johnson vaccine also have an improved antibody response following an additional dose of the same vaccine. At this time, no additional dose is recommended for people who had the Johnson & Johnson single-dose vaccine. People who received J&J should not get a second dose of either J&J or a dose of an mRNA vaccine.
While a third dose of vaccine is likely to increase protection, people who are immunocompromised should continue to wear a mask, maintain 6 feet of social distancing, avoid crowds, and avoid poorly ventilated indoor spaces. Close contacts of immunocompromised people are also strongly encouraged to be vaccinated against COVID-19 to further increase protection for those at greater risk.
Skagit County Public Health will now make third doses available to immunocompromised individuals at pop-up vaccine clinics and at our weekly vaccine clinic on Wednesday evenings from 6-9pm at the County Administrative Building (700 S 2nd St, Mount Vernon, WA 98273). Please bring your Vaccination Card with you when seeking a second or third dose. For information about our clinics, go to www.skagitcounty.net/COVIDvaccine or call (360) 416-1500.
To find a full list of vaccine providers near you, go to: https://vaccinelocator.doh.wa.gov/. For assistance call the COVID-19 Information Hotline at 1-800-525-0127, then press #. Language assistance is available.